Literature DB >> 7722842

Human antibody responses to outer envelope antigens of Porphyromonas gingivalis serotypes.

J L Ebersole1, M J Steffen.   

Abstract

Immunological studies examining the homogeneity of the major antigenic components of P. gingivalis have suggested 3 serotypes and have indicated a limited distribution of the serotypes in an individual patient. These studies prompted us to define the immunodominant antigens and distribution of immune responses to P. gingivalis serotypes. Serum IgG antibody levels in periodontitis patients in the present study were most frequently elevated above the normal subjects when tested against P. gingivalis serotype A (i.e., 33277). Nearly 1/3 of the patients showed significantly elevated antibody to multiple serotypes of the P. gingivalis apparently resulting from cross-reacting antigens. We determined distinctive differences among outer envelope protein and antigen patterns obtained from the three serotypes. Moreover, the results identified considerable similarities in the qualitative and quantitative antigen response patterns among patients to a particular serotype. There was a strong positive correlation between IgG antibody levels (ELISA) and the total level of reactivity determined in the immunoblots, as well as a positive correlation to the proportion of antibody to particular antigens. These findings suggest that responses to these antigens comprised a major portion of the response to the intact microorganism. Additionally, the detection of antibody to particular antigen bands was indicative of early responses to each of the P. gingivalis serotypes. The results of our study indicate that a subpopulation of periodontitis patients develop an extensive serum antibody response often to multiple serotypes of P. gingivalis and may define a patient population with a P. gingivalis disease. Finally, our results indicate a more consistent antigenic composition for P. gingivalis which may enhance the potential for strategies to immunologically interfere with disease caused by this microorganism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722842     DOI: 10.1111/j.1600-0765.1995.tb01247.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  7 in total

1.  The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration.

Authors:  Gabriela d'Empaire; Michael T Baer; Frank C Gibson
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

Review 2.  Periodontal disease immunology: 'double indemnity' in protecting the host.

Authors:  Jeffrey L Ebersole; Dolphus R Dawson; Lorri A Morford; Rebecca Peyyala; Craig S Miller; Octavio A Gonzaléz
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

3.  Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies.

Authors:  P J Pussinen; T Vilkuna-Rautiainen; G Alfthan; K Mattila; S Asikainen
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Heterogeneity of human serum antibody responses to P. gingivalis in periodontitis: Effects of age, race/ethnicity, and sex.

Authors:  J L Ebersole; M Al-Sabbagh; D R Dawson
Journal:  Immunol Lett       Date:  2019-12-18       Impact factor: 3.685

5.  A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis.

Authors:  Neil M O'Brien-Simpson; James A Holden; Jason C Lenzo; Yan Tan; Gail C Brammar; Katrina A Walsh; William Singleton; Rebecca K H Orth; Nada Slakeski; Keith J Cross; Ivan B Darby; Dorit Becher; Tony Rowe; Adriana Baz Morelli; Andrew Hammet; Andrew Nash; Anna Brown; Bing Ma; Didier Vingadassalom; Jacqueline McCluskey; Harold Kleanthous; Eric C Reynolds
Journal:  NPJ Vaccines       Date:  2016-12-01       Impact factor: 7.344

6.  Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.

Authors:  Dominique S Michaud; Jacques Izard; Charlotte S Wilhelm-Benartzi; Doo-Ho You; Verena A Grote; Anne Tjønneland; Christina C Dahm; Kim Overvad; Mazda Jenab; Veronika Fedirko; Marie Christine Boutron-Ruault; Françoise Clavel-Chapelon; Antoine Racine; Rudolf Kaaks; Heiner Boeing; Jana Foerster; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Carlotta Sacerdote; Sabina Sieri; Domenico Palli; Rosario Tumino; Salvatore Panico; Peter D Siersema; Petra H M Peeters; Eiliv Lund; Aurelio Barricarte; José-María Huerta; Esther Molina-Montes; Miren Dorronsoro; J Ramón Quirós; Eric J Duell; Weimin Ye; Malin Sund; Björn Lindkvist; Dorthe Johansen; Kay-Tee Khaw; Nick Wareham; Ruth C Travis; Paolo Vineis; H Bas Bueno-de-Mesquita; Elio Riboli
Journal:  Gut       Date:  2012-09-18       Impact factor: 23.059

7.  Humoral immune response to antigens of Porphyromonas gingivalis ATCC 33277 in chronic periodontitis.

Authors:  Mônica Franca; Lília Moura-Costa; Roberto J Meyer; Soraya C Trindade; Urbino da Rocha Tunes; Songelí M Freire
Journal:  J Appl Oral Sci       Date:  2007-06       Impact factor: 2.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.